-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IUNN5wxyg9Ebalvf7ha1FmEbseh7i2Op3KpADj2HbWOxRAxE17ENTVSdLiY2VIWC UKVyGcRsI2Q3tbxpaJ0sxQ== 0000897101-06-002565.txt : 20061212 0000897101-06-002565.hdr.sgml : 20061212 20061212151830 ACCESSION NUMBER: 0000897101-06-002565 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061208 ITEM INFORMATION: Other Events FILED AS OF DATE: 20061212 DATE AS OF CHANGE: 20061212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASCULAR SOLUTIONS INC CENTRAL INDEX KEY: 0001030206 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411859679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27605 FILM NUMBER: 061271452 BUSINESS ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 BUSINESS PHONE: 7636564300 MAIL ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 8-K 1 vascular064824_8k.htm FORM 8-K DATED DECEMBER 8, 2006 Vascular Solutions, Inc. Form 8-K Dated December 8, 2006
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report: December 8, 2006

(Date of earliest event reported)

 

VASCULAR SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Commission File Number: 0-27605

 

Minnesota

41-1859679

(State or other jurisdiction of incorporation)

(IRS Employer Identification No.)

 

6464 Sycamore Court

Minneapolis, Minnesota 55369

(Address of principal executive offices, including zip code)

 

(763) 656-4300

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  

Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ( 17 CFR 240.13e-4(c))

 


 
 


Item 8.01  Other Events.

On Friday, December 8, 2006, a trial date was set for the patent infringement lawsuit brought by Diomed Holdings, Inc. against Vascular Solutions Inc. and certain other defendants in March 2004 in the United States District Court for the District of Massachusetts. The case has been scheduled for a jury trial beginning on March 12, 2007. The trial is anticipated to last approximately two weeks with a verdict to be rendered by the jury shortly after the end of the trial. Diomed has asked for injunctive relief, compensatory and treble damages caused by the manufacture and sale of the Vascular products, and other costs, disbursements and attorneys’ fees. Diomed estimates Vascular’s liability for compensatory damages to be $7.0 million. Vascular believes that its products do not infringe on Diomed’s patents and that Diomed’s claims have no merit and will continue to vigorously defend the lawsuit brought by Diomed.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

VASCULAR SOLUTIONS, INC.

 

 

 

 

 

 

By:

/s/ James Hennen

 

 

 

James Hennen
Chief Financial Officer

 

Date:  December 11, 2006

 

 



 -----END PRIVACY-ENHANCED MESSAGE-----